News Archive

A special programme for empathy education developed at University of Galway is to be expanded into Transition Year (TY) in secondary schools nationwide.Activating Social Empathy is a practical classroom resource designed to help teachers promote empathy skills and understanding among young people in the Senior Cycle.The programme was developed by researchers at the UNESCO Child and Family Research Centre at University of Galway, along with colleagues in the University’s School of Education, working closely with a Youth Advisory Panel from Foróige. It is endorsed by the National Council for Curriculum Assessment.Actor Cillian Murphy is a patron of the UNESCO Child and Family Research Centre at University of Galway and a supporter of the empathy education initiatives.  Described as a new micro-module, the new TY course complements the existing Junior Cycle Activating Social Empathy resource which was announced in 2020. It offers age-appropriate lessons and activities that challenge TY students to explore empathy in more complex social contexts.            Dr Charlotte Silke, lead researcher with UNESCO Child and Family Research Centre, University of Galway, said: “The core aim is to support young people in becoming more attuned to the feelings and perspectives of others, and more confident in expressing empathy across a variety of real-world contexts.”  The Activating Social Empathy schools programme is supported by the Irish American Partnership and Lifes2good Foundation, Cillian Murphy and partners of the UNESCO Child and Family Research Centre, Foróige and Penn State. The TY micro-module, is informed by theory and practice in the area of social and emotional learning and the resources are underpinned by research evidence relating to the development and expression of empathy during adolescence.It is designed to strengthen students’ empathy skills through 10 interactive lessons, using scenarios and video and other learning methodologies supplemented by comprehensive sample materials. The programme encompasses three interconnected components: Cognitive Empathy (i.e., awareness or understanding of others’ perspectives); Emotional Empathy (i.e., feeling with, or for, another person), and Empathic Action (i.e., translating understanding and feelings into supportive, helpful actions). Students also learn about strategies to address empathy barriers and engage in empathic actions across diverse contexts.            Professor John Canavan, UNESCO Chair, Children, Youth and Civic Engagement and Director of the UNESCO Child and Family Research Centre, University of Galway, said: “For young people growing up in a world marked by rising social polarisation, environmental crises and mental health issues, socio-emotional and behavioural skills are increasingly valued as part of education policies designed to address broad dimensions of learning. Empathy is a process of understanding others' perspectives, feeling for others and taking supportive action."The Activating Social Empathy Manual is available as a free resource to all schools in Ireland and can be accessed here: https://tinyurl.com/33rfvmus  Ends

UNiTE to end violence against women #NoExcuse University of Galway is joining with 15 third level education institutions in Ireland as part of the global campaign - 16 Days of Activism against Gender-Based Violence. This is our second year collaborating on this important campaign. The campaign gets underway today Tuesday November 25th - the International Day for the Elimination of Violence against Women. The UNiTE 2025 campaign focuses on one of the fastest-growing forms of abuse: Ending digital violence against all women and girls. This year’s campaign is also a reminder that digital safety is central to gender equality. Dr Helen Maher, Vice President for Equality, Diversity and Inclusion at University of Galway, said: “As a university community, we are committed to fostering a safe, respectful and inclusive environment for all. Our work on preventing and responding to gender-based violence reflects this responsibility. Informed by research, policy and best practice, we aim to raise awareness, support those affected, and strengthen a culture grounded in dignity, equality and accountability. Through a collective and evidence-based approach, we strive to ensure that every member of our community feels protected, valued and empowered.” Niamh Kavanagh, Sexual Violence Prevention and Response Manager at University of Galway, said: “The University of Galway is proud to join forces with our Equality, Diversity and Inclusion (EDI) and SVH (Sexual Violence and Harassment) colleagues from 15 other higher-education institutions nationwide - to deliver a meaningful, sector-wide response to this year’s 16 Days of Activism campaign.Together we are committed to raising awareness, standing in solidarity with survivors, and driving an inclusive culture of prevention, accountability and respect across the education sector.” The 16 Days of Activism campaign runs until December 10th (Human Rights Day). It was launched in 1991 by the Women’s Global Leadership Institute as a call to prevent and eliminate gender-based violence worldwide. Now, with the backing of the United Nations Secretary-General’s UNiTE by 2030 to End Violence against Women campaign, universities, organisations, and individuals around the globe are joining the cause. University of Galway calls upon students, staff, and the wider community to participate in these 16 Days of Activism to foster a world where no woman or girl lives in fear of violence. What is digital abuse? Digital tools are increasingly being used to stalk, harass, and abuse women and girls. This includes: - Image-based abuse/non-consensual sharing of intimate images – often called revenge porn or leaked nudes. - Cyberbullying, trolling, and online threats. - Online harassment and sexual harassment. - AI-generated deepfakes such as sexually explicit images, deepfake pornography, and digitally manipulated images, videos or audio. - Hate speech and disinformation on social media platforms. - Doxxing – publishing private information. - Online stalking or surveillance/tracking to monitor someone’s activities. - Online grooming and sexual exploitation. - Catfishing and impersonation. - Misogynistic networks – e.g. manosphere, incel forums. How to Get Involved - Promote Zero Tolerance: Use your voice to spread a message of zero tolerance for violence against women and girls. - Engage Leaders: Advocate for policies that enforce zero tolerance towards violence and protect women’s rights. - Support Local Women’s Organisations: Donations and volunteer support are critical to the success of these organisations. - Share Awareness Using #NoExcuse: Amplify the message on social media, in schools, workplaces, and communities. - Wear or display the colour orange – a symbol of hope and a future free from violence. Join the 16 Days conversation on social media The national campaign at third level institutions includes University of Galway; Atlantic Technological University; Dublin City University; Dundalk Institute of Technology; IADT - Institute of Art, Design and Technology; Mary Immaculate College; Munster Technological University; Maynooth University; South East Technological University, Technological University Dublin; Technological University of the Shannon, University College Cork; University College Dublin; University of Limerick; Royal College of Surgeons in Ireland; and Trinity College Dublin. Read more about University of Galway’s Sexual Violence and Harassment Prevention and Response Programme of work here and about the 16 days of Activism against Gender Based Violence schedule of events here and via  Instagram and LinkedIn.  Ends

University of Galway has recognised seven primary and secondary schools for their outstanding commitment to creating welcoming, inclusive, and safe environments for all students. The awards ceremony was held at the University’s Institute for Lifecourse and Society, celebrating the official designation of the seven schools as Champion Schools of Sanctuary. A Champion School of Sanctuary is the highest level of the Schools of Sanctuary programme, which follows a "Learn, Action, Share" framework to foster a culture of welcome, challenge prejudice and build understanding about forced migration. These schools demonstrated actively embedding inclusion across the school community. The seven designated Champion Schools of Sanctuary are: Coláiste Muire Máthair, Galway Galway Educate Together Secondary School Ballyhaunis Community School, Co. Mayo Brusna National School, Co. Roscommon Our Lady of Lourdes Primary School, Limerick Sancta Maria College, Louisburgh, Co. Mayo Ballinlough National School, Co. Roscommon The awards ceremony was hosted by the Office of the Vice-President for Equality, Diversity and Inclusion and the Access Centre at University of Galway, in collaboration with Schools of Sanctuary Ireland and Galway City Partnership. The event underscores the University’s commitment to advancing equality and inclusion within the education sector and beyond. Dr Helen Maher, Vice-President for Equality, Diversity and Inclusion at University of Galway, said: “At University of Galway, we are deeply committed to fostering a culture of inclusion and belonging - not only across our campus, but within the wider education system. The Champion Schools of Sanctuary embody these same values, creating learning environments where every student feels seen, supported, and valued. By recognising and celebrating these schools, we are also acknowledging the powerful role education plays in shaping compassionate, empathetic communities.” Imelda Byrne, Head of the Access Centre at University of Galway, said: “At University of Galway Access Centre, we are deeply committed to fostering inclusion at every level of education. The Schools of Sanctuary initiative reflects that same spirit - it’s about ensuring every learner feels seen, supported, and valued. We’re proud to celebrate these schools for creating spaces where belonging isn’t just encouraged, it’s lived every day.” Cllr. Helen Ogbu, Galway City Council, who has supported the work in schools, said: “Across counties and communities, these schools are demonstrating real leadership in creating inclusive and welcoming environments for every student. I’m proud to support their achievements today and to acknowledge the important partnerships driving this meaningful work.” Sara Hakim, Director of Schools of Sanctuary Ireland, said: “In a current climate of anti-migrant activity and unrest, the granting of this official status to these seven schools is timely. These schools have made a commitment to ensuring their school shines as a beacon of inclusion, welcome and equality.” Dr. Veronica Crosbie, Chairperson of Places of Sanctuary Ireland, said: “This awards ceremony is an opportunity to celebrate the fantastic integration initiatives happening across the Irish educational landscape, often quietly under the radar of local and national media.” The awards ceremony was funded by the Office of the Vice-President for Equality, Diversity and Inclusion and Access Centre at University of Galway, and Galway City Partnership. Ends

University of Galway has welcomed 19 research students to campus as part of the 2025 Hardiman PhD Scholarship. The new scholars have come from 11 different countries to take part in the scheme and the opportunity to pursue a structured doctorate at the University on topics aligned to our research pillars of Innovation for health; Creativity, culture & society; Sustainable & resilient environments: earth & ocean; and Transformative data & AI. Applications for the 2026 round of Hardiman PhD Scholarships will open on Monday December 1st, 2025, and will remain open until Friday February 6th, 2026 at 5pm. For more information or to apply for a Hardiman PhD Scholarship visit: www.universityofgalway.ie/hardiman-scholarships Professor Dónal Leech, Dean of Graduate Studies at University of Galway, said: “I welcome our excellent Hardiman Research scholar recipients to the University. The 19 scholars were selected from a large pool of applicants seeking to develop their research skills and independence through our renowned structured PhD programmes across our four research pillars, to deliver distinctive research impact. The scholarship is a recognition of excellence for the awardees and provides fee and stipend support over four years for the researchers to generate new knowledge that improves our world.” The Hardiman PhD Scholarships are open across all four Colleges at University of Galway. The 2025 Hardiman PhD scholars and their subject areas include: College of Arts, Social Sciences, and Celtic Studies Makalay Sonda, Sierra Leone - Analysing the gendered impacts of online violence against women in politics with case studies of Ireland and Sierra Leone. Nicole O'Byrne, America - Embodied New Mythology for Climate Activism: Deep Ecology and Ritual Performance in Contemporary theatre in Ireland. In the field of Drama and Theatre Studies. Maitiú Mac Cárthaigh, Ireland - Good Queers? The Sexual Politics of Irish Rural Futures – a research-led creative practice. Allison Fairfield Hart, Canada - Research on the acceptability, feasibility, and effectiveness of an online course for parents to address food selectivity in their children. Daniel Gallen, Ireland - An oral history of Irish LGBTQ+ emigration to New York, San Francisco, and New Orleans. Philip Keegan, Ireland - The Interplay of Policy, Media, and Public Opinion on Migrants and Migration in Ireland. Cara Coffey, Ireland - Adapting the Preschool Life Skills Programme: Enhancing Inclusion in Early Childhood Education in Ireland. College of Business, Public Policy and Law Pratik Purswani, India - Studying disruptive climate protests under international human rights law. Abass Kargbo, Sierra Leone - The Long-Term Effects of Additional Schooling in the Developing World. Eden Mulugeta, Ethiopia - Digital memorials and their role in intergenerational memory, transitional justice, and peacebuilding in post-conflict African societies. Amil Jafarguliyev, Azerbaijan - Remedying Barriers to Entry Posed by Lock-in Effects in Digital Markets Through Mandated Interoperability and Data Portability under European Union Law. College of Medicine, Nursing and Health Sciences Patricia Harte, Ireland - Evaluating the impact of a community-based mental health promotion initiative, Act Belong Commit, on the mental wellbeing of participants. Lara Ressin, Germany - The influence of brain architecture on functional connectivity and how this relationship relates to cognition and bipolar disorder. Emily Cronin, Ireland - Investigating the role of damp hospital environments as persistent reservoirs for antimicrobial resistant bacteria that can colonise and infect patients. Aiden Vassilian, France - Engineering of CAR-T cells to hijack tumour immunosuppression, enhancing persistence, and improving outcomes in colorectal and ovarian cancers. College of Science and Engineering Abdul Mateen Khan, Pakistan - Sustainable construction through digitalization and BIM integration, focusing on energy efficiency, lifecycle optimization, and productivity in modern building practices. Brandon Collier, America - Characterising the adaptive traits of globally invasive widow spider species. Nikita Gondalia, India - Investigating the novel genes and pathways controlling haploid induction in plants, opening innovative strategies to enhance global crop breeding efficiency. George Aryee, Ghana - Predicting Peripheral Artery Disease outcomes using Electrocardiogram, lifestyle and clinical factors.  Ends

Spiorad Medical leads on breakthrough cardiovascular medical device to simplify procedures and improve patient recovery A consortium led by University of Galway medtech startup Spiorad Medical has secured a €1.7million euro investment through the Government’s Disruptive Technologies Innovation Fund (DTIF). Spiorad Medical aims to develop a next-generation vascular closure device to simplify cardiovascular procedures while improving outcomes and recovery for patients. The device is designed to stop bleeding quickly and safely during structural cardiovascular procedures such as TAVI or EVAR that use larger tubes or access devices. The successful consortium is a partnership involving Spiorad Medical, University of Galway and Dolmen Design and Innovation Ltd, combining breakthrough medtech and the University’s research expertise with Dolmen’s leading product design capabilities. Judi O’Malley, Co-founder and CEO of Spiorad Medical, said: “With this DTIF award, we can accelerate the development of advanced cardiovascular procedures and deliver better outcomes for patients. Our ambition as a consortium is to help transform vascular closure technology, delivering greater access, ease of use and improved solutions to the interventionalist’s challenge - resulting in better clinical outcomes and faster recovery for patients.” Professor Lokesh Joshi, Vice President for Research and Innovation at University of Galway, said: “Congratulations to Judi O’Malley, the Spiorad team, the University of Galway, and Dolmen Design and Innovation for this fantastic achievement under the Disruptive Technologies Innovation Fund. This is another great example of a University of Galway startup delivering real impact for patients and clinicians.” Spiorad Medical is an Enterprise Ireland HPSU client company based at University of Galway’s Business Innovation Centre. University of Galway research and innovation has led to 21 new spin-outs being created and 195 new inventions since 2020. University of Galway is also part of 35 consortia which have successfully applied to the Government’s Disruptive Technologies Innovation Fund. University of Galway’s Galway’s Business Innovation Centre is supported under the KT Boost Programme, co-funded by the Government of Ireland and the European Union through the Northern & Western Regional Programme 2021-2027. Ends  

Documentary explores how clinical trials are transforming diabetes care through collaboration with patients  Imperfect Days, a new Science on Screen documentary highlighting how clinical trials are transforming healthcare for people living with diabetes, will premiere at The Pálás Cinema, Galway City, on Sunday afternoon, December 7th.  Directed by David Qualter and produced by Laura Qualter of Prospect Films, Imperfect Days brings audiences into the lives of Carmel McDonagh, Tony Marshall and Faye Burke, who share their personal experiences of managing diabetes and participating in clinical trials.  The film also features leading researchers and clinicians from University of Galway, Galway University Hospitals and the Royal College of Surgeons Ireland, including Professor Fidelma Dunne, Director of the Institute for Clinical Trials at University of Galway; Professor Seamus Sreenan; Professor Matt Griffin; and Dr Christine Newman, who are at the forefront of clinical trial research and innovation in Ireland and are seeing firsthand its transformative effects.  The 25-minute documentary was produced with funding from a Health Research Board grant to the Diabetes Collaborative Clinical Trial Network, under the umbrella of Science on Screen, - a partnership between CÚRAM, the Research Ireland Centre for Medical Devices at University of Galway and Ardán, the Galway-based film and television agency.  Filmed in Dublin and Galway, Imperfect Days explores – with both sensitivity and humour – the day-to-day realities of living with diabetes. The film also shines a light on how clinical trials and public and patient involvement (PPI) are driving progress in diabetes research and care. Through pioneering trials in areas including gestational diabetes, cardiovascular disease and related chronic conditions, the Diabetes Collaborative Clinical Trial Network is advancing research that is conducted not only for patients but with them, through meaningful PPI collaboration. David Qualter, Director, Prospect Films said: “This film is really about partnership - between researchers, clinicians, and the people who live with diabetes every day, We wanted to show how collaboration and clinical research are not abstract ideas, but real forces that are changing lives across Ireland. It was great to work with Ardán and CÚRAM on this project and an honour to be tasked with creating the 10th documentary of the fantastic Science on Screen scheme.”  Professor Fidelma Dunne, Director, Diabetes Collaborative Clinical Trial Network and Director of the Institute for Clinical Trials at University of Galway, said: “Clinical trials are the bridge between scientific discovery and real-world impact. Through the Diabetes Collaborative Clinical Trial Network, we’re ensuring that research in Ireland reflects the priorities and lived experiences of people living with diabetes. Imperfect Days highlights just how vital that partnership has become.”  Professor Abhay Pandit, founding Director of CÚRAM, said: “We’re delighted to have partnered with the Diabetes Collaborative Clinical Trial Network for this latest film. This is the 10th film produced through our Science on Screen programme, and it is another powerful and engaging example of scientific storytelling that we hope will reach a wide audience. Congratulations to the filmmakers and participants on an excellent production.”  Alan Duggan, Ardán Chief Executive, said: "For more than ten years, the collaboration between Ardán and CÚRAM through Science on Screen has played a huge part in Ardán’s goal to create opportunities for emerging filmmakers. The documentaries created not only highlighted the groundbreaking research taking place at CÚRAM, but also reminds us that behind every illness or diagnosis there is a human story to be told. Science on Screen not only makes STEM subjects more accessible to the media audience but also provides valuable insights into the extraordinary work that is shaping the future of medicine." Ends

Satellite-based Earth observation provides a unique and powerful tool in tracking climate adaptation, an international study involving University of Galway researchers has shown. A team at the University’s Ryan Institute is helping to pioneer new methods of combining data recorded from space with artificial intelligence to measure actions that help communities, ecosystems and infrastructure adjust to current and future climate impacts in the global agrifood sector. The science behind it allows assessments of even the most remote agricultural regions in the world, where ground measurements are sparse or too challenging. The findings feature in a European Space Agency (ESA)–led study, published this week in npj Climate and Atmospheric Science to coincide with COP30. The researchers mapped the potential for Earth observation in supporting different targets in the framework for the Global Goal on Adaptation (GGA), a key action under the Paris Agreement from 2015, which aims to enhance resilience and reduce vulnerability to climate impacts. Their analysis found that many of the most critical changes to climate, known as Essential Climate Variables (ECVs), can be directly used to understand and support climate adaptation action. Focusing on four key sectors – agriculture, biodiversity, extreme events and health – the study reveals how space-based data offers something no other monitoring system can provide: truly global coverage with objective and repeatable measurements spanning up to 60 years. Professor Aaron Golden, research team leader at the University’s Ryan Institute and co-author of the study, said: “The analysis highlights the vital and unique role satellites play in supporting the Paris Agreement’s Global Goal on Adaptation. The knowledge capability of consistent, long-term observations offers policymakers tools to measure progress and identify regions at risk.” The research team highlighted concrete applications of earth observation science across four key themes: Agriculture: satellites monitor water productivity, irrigation efficiency, and crop migration patterns. Biodiversity conservation: platforms like Global Mangrove Watch and Global Forest Watch provide crucial geospatial information on ecosystem extent and changes. Extreme events: satellites characterise flood extent, drought anomalies and urban heat islands at scales impossible with ground-based stations alone. Health sector: Earth observation data on land surface temperature and air quality inform heat exposure assessments and disease outbreak forecasting. Dr Sarah Connors, Climate Applications Scientist at ESA, the study's lead author said: "Earth observation data should be considered as an integral part of the Global Goal on Adaptation indicators. Our research demonstrates that satellite data can inform adaptation tracking across many sectors, but it must be integrated into the indicator framework from the outset – as experience with the Sustainable Development Goals shows, it’s much harder to introduce later."             Professor Frances Fahy, Director of the University of Galway's Ryan Institute, said: "This research exemplifies the world-class, impact-driven research emerging from the Ryan Institute and our growing Geospatial Centre. By using satellite Earth observation data to better understand and track global climate adaptation, Professor Golden’s work reinforces the vital role that cutting-edge interdisciplinary research plays in addressing the climate crisis and shaping international climate policy." Professor Golden added: "I am delighted the impact our research in quantifying climate adaptation in food production using AI and earth observation data has had in providing a direct means of linking facts on the ground, anywhere on the planet, to the Paris Agreement's Global Goal on Adaptation indicators." The full study, published in npj Climate and Atmospheric Science, is available at https://www.nature.com/articles/s41612-025-01251-1. Ends

University of Galway’s ReelLIFE SCIENCE awards for schools and youth groups in 10 counties From AI to allergies and dopamine to the deep sea, short science videos made by young Irish filmmakers have been celebrated at the 13th Annual ReelLIFE SCIENCE Awards in University of Galway. The event took place on Sunday November 9th as part of Science Week 2025 and the 27th Galway Science and Technology Festival. More than 200 short science films were entered into the competition created by 1,800 young science enthusiasts in 86 schools and youth groups taking part across the island of Ireland. Winning videos were selected by a panel of guest judges including science communicators Mark Langtry – The Science Guy; Amy Hassett, University College Dublin; and the 2025 BT Young Scientist and Technology Exhibition winners, Ciara, Saoirse and Laoise Murphy, from Presentation Secondary School, Tralee, Co Kerry. ReelLIFE SCIENCE Winners – Primary 1st Prize – Twenty-three talented sixth class students from Gaelscoil Riabhach in Loughrea, Co Galway, along with their teacher Brian Ó Meacháin, won the €1,000 first prize for their animated video ‘An Fharraige Dhomhain’ exploring The Deep Sea.Runners-up – Inspired by an episode of Fr. Ted, teacher Thomas Egan and sixth class students from Sooey National School in Sligo explained the workings of the eye in their humorous video ‘Small or Far Away?’ Finishing third, and led by teacher Tommy Buckley, fifth class students from Killorglin National School in Kerry made a science music video entitled ‘Why do Cats Always Land on their Feet’, while teacher Clíodhna O’Donnell and 28 sixth class students from Abbey Primary School in Boyle, Co. Roscommon came fourth for their study of levers and pulleys, ‘Machine Made Possible’. ReelLIFE SCIENCE Winners – Post-primary 1st Prize – Seven first and second year students from Coláiste Ghobnait on Inis Oírr, Co na Gaillimhe, won the €1,000 first prize under the guidance of science teacher Rebecca Ní Chríocháin, for their video ‘Céard is cúis le ailléirgí?’ explaining the causes of allergies through Irish. Runners-up – Sixth year students Shaun Irimpan and Gabriel McCrystal from Coláiste Na Mí, Navan, Co. Meath, highlighted the negative impacts of artificial intelligence in their video ‘What Happens When Everyone Uses AI?’ The third-place prize went to Transition Year students Evanna Moneley, Jasmine Zhang and Asia Aru from Alexandra College in Dublin for their video ‘Everything we need to know about Dopamine’, while fourth prize was awarded to Saipresha Paraneetharan, Alannah McCarthy, Zara Jaiby and Lily Hutton from Tullow Community School in Carlow for their science music video ‘Why do we Hiccup?, ReelLIFE SCIENCE Winners – Youth Organisation 1st Prize – A group of 12 young people from Athlone, Co Westmeath who took part in My Life Online workshops facilitated by Midlands Science and Foróige and supported by the Rethink Ireland TikTok Digital Future Fund, won the €1,000 youth group first prize for their video ‘Why is the Sky Blue’.    Runners-up – Brogan O’Donnell from Trident Swim Club in Carrick on Shannon, Co. Leitrim came second for his underwater video exploring ‘The Science of Swimming’. Eddie Sweeney and Brooklyn Conroy from Ballybane Foróige in Galway were third for their science experiments video ‘My life as…a Scientist’, while six young people from Ballyphehane and Greenmount Foróige group in Cork finished fourth for their video ‘The Science of Coke and Mentos’.   Special Category Awards     Carrigallen National School, Leitrim Agricultural Science Award Bunclody Community College, Wexford Best Acting Award Mount Anville Secondary School, Dublin Best Animation Award Gaelscoil Uileog de Búrca, Mayo Físeán Gaeilge is fearr Royal School Cavan How Things Work Award Ennis National School, Clare Junior Scientists Award Presentation Primary Listowel, Kerry Teamwork Award  All of the winning videos can be viewed at https://www.youtube.com/ReelLifeScience.  The ReelLIFE SCIENCE programme challenges young people in schools and youth groups across the island of Ireland to engage with science and technology while developing their communication and digital skills, by producing short educational videos for the public.  Since being launched in 2013 by Dr Enda O’Connell and a team of scientists from University of Galway’s College of Science and Engineering, this challenge has been met by more than 30,000 young people, supported by teachers and staff in 825 schools and youth groups.  Dr O’Connell said: “Every year, we’re amazed by the imagination, creativity and curiosity shown by young people across Ireland. Through ReelLIFE SCIENCE, they bring science to life in ways that are funny, thought-provoking and inspiring, making it accessible to everyone. We’re incredibly proud of all the students, teachers and youth leaders who took part this year. A big congratulations to every one of them for sharing their passion for science with the world.”  ReelLIFE SCIENCE is supported by the Research Ireland Discover Programme, University of Galway’s College of Science and Engineering, the CÚRAM - the Research Ireland Centre for Medical Devices at University of Galway, the Cell EXPLORERS programme and Foróige. Ends    

Two University of Galway academics have been named among the world's most cited researchers. Professor Henry Curran and Professor Ines Thiele have once again joined the prestigious Clarivate Highly Cited Researchers 2025 list. They are among almost 7,000 researchers from more than 1,300 institutions who have demonstrated significant influence in their fields of research through the publication of multiple highly cited papers over the last 11 years. Professor Lokesh Joshi, Vice President for Research and Innovation, University of Galway, said: “I warmly congratulate our academics – Professors Henry Curran and Ines Thiele - who have once again joined the world’s most highly cited researchers list from Clarivate. To be part of this prestigious global group highlights the quality and impact of their work in developing novel solutions in engineering and healthcare. It also demonstrates the strong commitment to research excellence at University of Galway.” Professor Henry Curran, listed in the Engineering category, is Director of the Combustion Chemistry Centre at the School of Biological and Chemical Sciences, College of Science and Engineering and of the Energy Research Centre in the Ryan Institute at University of Galway. His research looks at the study of the chemistry of how fuels burn in combustors to increase efficiency and reduce emissions for a cleaner world. This is Professor Curran’s 11th year being named a Clarivate Highly Cited Researcher. Professor Ines Thiele, listed in the Cross-Field category, is Professor of Systems Biomedicine and principal investigator of the Molecular Systems Physiology group at University of Galway’s College of Medicine, Nursing and Health Sciences. Professor Thiele has been pioneering the development of digital metabolic twins for humans and human associated microbes. Her team uses these digital twins to develop innovative approaches to accelerate the diagnosis of inherited metabolic diseases and to enable the prediction of personalised treatment strategies. This is Professor Thiele’s third year being named a Clarivate Highly Cited Researcher. David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate said: “The Highly Cited Researchers list identifies and celebrates exceptional individual researchers at University of Galway who demonstrate significant and broad influence in their fields. They exemplify excellence in their research as well as integrity in their publication and citation practices. These researchers continue to shape the future of science, technology and academia globally and deliver innovation that drives societal progress.” The full 2025 Highly Cited Researchers list can be viewed here: https://clarivate.com/highly-cited-researchers/ Ends

University of Galway has marked the 50th anniversary of Druid with a special symposium, a new book being launched and an exhibition of materials from the Druid archive. Druid at 50: People, Place & Performance featured a mix of free public talks and discussions exploring Druid’s journey over the past five decades – from its roots in Galway to its status as one of Ireland’s leading theatre companies – and its vision for the future. University of Galway and Druid announced a 10-year strategic partnership in 2022, expanding academic links, student engagement, local and global events and the creative sector in the west. The University is the theatre company’s exclusive academic partner, with Druid offering internship opportunities and working to strengthen and enhance the success of University Creative Arts programmes. The Druid archive is also part of the University of Galway Library’s collections, offering students and researchers the opportunity to explore the company’s rich history. The anniversary symposium was organised by the Department of Drama and Theatre Studies, led by Druid Lecturer, Dr Máiréad Ní Chróinín. The programme included a keynote conversation with Druid Artistic Director Garry Hynes and Set and Costume Designer Francis O’Connor, as well as artist and academic panels. A new exhibition from the Druid archive, which is hosted by the University of Galway Library, has been produced, looking back over 50 years of the company. The exhibition was officially opened by Professor David Burn, President of University of Galway, along with Maureen Kennelly, newly appointed Chief Executive Officer of Druid and alumna of the University. It will run at the University of Galway Library through to February 2026. A display of Druid model boxes featured in the foyer of the O’Donoghue Centre as part of the anniversary symposium. The event also celebrated the publication of a new book, Druid Theatre 1975–2025: New Irish Plays, edited by Dr Barry Houlihan, Professor Patrick Lonergan and Dr Máiréad Ní Chróinín. The 50th anniversary anthology collects six significant plays produced by Druid, including works by M.J. Molloy, Geraldine Aron, Tom Murphy, Vincent Woods, Martin McDonagh and Nancy Harris. Professor David Burn, President of University of Galway, said: “Druid’s story is inseparable from that of Galway itself. It is a story of creativity, collaboration and world-class ambition rooted in the West of Ireland. As we celebrate 50 years of Druid, we also celebrate the spirit of innovation and community that has shaped both the theatre company and our University. Our partnership with Druid reflects our shared commitment to supporting the next generation of artists and cultural leaders. It is a privilege for University of Galway to honour Druid’s remarkable legacy and to look ahead to the next fifty years of inspiring performance and creativity." Monica Crump, University Librarian, said: “The Druid Archive offers a unique insight into the creative processes and cultural impact of one of Ireland’s most celebrated theatre companies. We are proud to make these materials available for research, learning and inspiration as we celebrate fifty years of Druid’s contribution to Irish and international theatre and to preserve them for future generations.” Garry Hynes, Druid’s Artistic Director added: “It is a great honour for Druid to be welcomed back to University of Galway for this symposium marking our 50th anniversary. In 1975, I co-founded Druid with two fellow university graduates, Marie Mullen and the late Mick Lally. 50 years later, this symposium offers us a wonderful opportunity to reflect on what Druid has achieved in its first five decades and consider where we will go in our next five decades. On behalf of all the Druids, I wish to extend our gratitude to the President of University of Galway, Professor David Burn, to the faculty members at the Department of Drama and Theatre Studies, the staff of University of Galway Library, and the wider academic community for making this symposium possible.” Dr Máiréad Ní Chróinín, Druid Lecturer and organiser of the event, said: “We’re thrilled to bring together artists, academics, students, and audiences to share in the energy, creativity, and ambition that Druid have cultivated for half a century. It’s about honouring the company’s roots while also looking forward with excitement to the next fifty years of storytelling, collaboration, and imagination.” The anniversary celebration event also coincides with a showcase of the Jerome Hynes One-Act Play Award 2025, The Swallowed Men, a student led production that was also the proud recipient of the “Druid 50th Anniversary Award”. The showing is part of University of Galway’s Arts in Action programme. Ends

University of Galway and EY unveil new executive training  Minister for Further and Higher Education, Research, Innovation and Science James Lawless T.D. has today launched a new cybersecurity executive education programme at University of Galway.   Cybersecurity for Managers is a new cyber awareness initiative developed and delivered by the University’s J.E. Cairnes School of Business & Economics in collaboration with EY, with the first intake in early 2026.    The programme is designed for people in leadership roles with no specific background in cyber or IT security and is focused on managers, team leaders, project managers and members of staff with managerial responsibility.   Minister for Further and Higher Education, Research, Innovation and Science James Lawless T.D. said: “Cyber threats are becoming more complex all the time, and it’s crucial that our leaders have the tools they need to stay ahead of the risks. This new programme is a strong example of how industry and education can work together to build the expertise required to strengthen our systems and support the people who rely on them. I’m really pleased to see this kind of practical, forward-thinking collaboration between the University of Galway and EY, and I look forward to the impact it will have across the healthcare sector and beyond.”  Professor Becky Whay, Deputy President & Registrar of University of Galway, said: “Our University is deeply committed to driving collaboration with industry leaders such as EY which enable our academics to build impactful education. The cybersecurity education programme is a great symbol of this, and through it we are equipping managers with the tools they need to support their organisations in an increasingly digital world, and the opportunities and challenges that go with that.”  Professor Alma McCarthy, Dean of the College of Business, Public Policy and Law at University of Galway, said: "In today’s rapidly evolving digital landscape, cyber security is more critical than ever. It is essential that management teams across all sectors are equipped with the knowledge and skills to address cyber challenges. University of Galway’s co-development of the cyber executive education programme with EY reflects our commitment to empowering leaders with practical, cutting-edge expertise for the future."   Puneet Kukreja, Technology Consulting Partner and Head of Cyber at EY Ireland, said: “Cybersecurity is now a national priority, central to resilience, trust, and economic stability and EY Ireland is proud to support the launch of the Cybersecurity for Managers programme at University of Galway.  EY’s Cyber Leaders Index published just last week shows that while 83% of organisations have strengthened their cyber defences in the past six months, only 39% provide regular training, and 48% rank AI and data security as a top priority even as 44% say funding remains constrained. Closing these gaps through education and awareness is key, and EY is helping build the leadership and skills to thrive securely in the AI era.” The cybersecurity programme will initially focus on the healthcare sector before being expanded to other sectors. It examines core concepts of cyber awareness including risk; understanding relevant threats, attack strategies and vulnerabilities; identity and access management; governance, policy, legislation and standards; human behaviours in cyber; metrics; cyber incident response and resilience.   The course marks the first stage in a new strategy led by the J.E. Cairnes School of Business and Economics at University of Galway to develop a broader suite of Executive Education programmes. The second strand will be on Artificial Intelligence for SMEs, which is also due to come on stream in 2026.    The initiative builds upon the experiences of the academics and researchers associated with the MSc Cybersecurity Risk Management postgraduate degree and the MBA programme at the J.E. Cairnes School of Business & Economics.   The development of the University’s executive education programme in cyberawareness was also supported in the Oireachtas by Senator Gerard Craughwell.   Ends 

Youth Academy, the University of Galway’s flagship outreach programme for high ability pupils in primary and post-primary school, has renewed its partnership with Merit Medical. Merit Medical is a leading multi-national medical device company with significant operations in Galway, employing almost 1,000 people. Over the next five years, the University’s partnership with Merit Medical will enable further development of the Youth Academy programme, opening doors for young learners from diverse backgrounds, inspiring them through innovative activities and providing insights into future careers. Since its launch in 2012 with 64 participants, Youth Academy has grown to welcome more than 8,000 young people and their families to the University of Galway campus, providing opportunities for them to explore their passions, develop new skills and experience university life with like-minded peers. Youth Academy provides high-level, Saturday classes run over six weeks in the Spring and Autumn. Summer camps in science, engineering, computer science and arts are also delivered to primary and secondary school pupils by University of Galway researchers and educators who are committed to fostering a friendly, inclusive, and supportive learning environment.             Professor David Burn, President of University of Galway, said: “University of Galway is very proud of our collaborations with industry to grow and support the pipeline of future students and talent in the region. We are delighted to announce the continuation and strengthening of our partnership with Merit Medical, marking a significant philanthropic investment in the University’s Youth Academy. This renewed commitment will empower and enhance the programme that Merit Medical has supported since its inception, fuelling its growth and impact for young learners across the region.” Since 2019, Merit Medical has supported the expansion of the Youth Academy programme to include post-primary students for the first time, reach more students in the Galway region and beyond, and has supported full scholarships for students from disadvantaged backgrounds, broadening participation and equity of access.           Mark Butler, Executive Vice President, European Operations, Merit Medical, said: “We're delighted to renew Merit Medical's partnership with the Youth Academy and the University of Galway - a cornerstone of our local community and a place where young people can discover their potential. At Merit Medical we believe that investing in youth is investing in the future. By working together, we're helping to build confidence, opportunity, and connection - strengthening the community we're proud to be part of." A recent study of the long-term impact of Youth Academy participation revealed that it has a very positive influence on chosen Leaving Cert subjects and is a motivation to study at third level. The study identified that 87% of parents reported that participation had opened their child’s mind to new areas of study and possible careers. In addition, two thirds reported a positive or highly positive impact for female pupils in challenging gender stereotypes in Science, Technology, Engineering and Mathematics (STEM) subjects. Read more about Youth Academy here: https://www.universityofgalway.ie/youthacademy/ Ends

University of Galway’s J.E. Cairnes School of Business and Economics has been announced as EY Luxembourg’s first higher education partner in Ireland and the UK. The partnership strengthens a relationship that has supported student development for more than two decades. The expanded link between the University and EY Luxembourg will offer students access to world-class expertise thanks to a suite of collaborative initiatives, including an annual summer school in alternative investments; direct mentorship from EY Luxembourg professionals; as well as employability activities and work placements opportunities. The partnership will also include guest lectures embedded in Management Accounting – reaching more than 550 undergraduate students. The partnership was officially launched with a visit by alumnus Robert White, Partner – Market Leader – EY Luxembourg; Europe West Wealth and Asset Management Assurance Leader on a visit to the campus. Speaking at the launch, Robert White said: “EY Luxembourg has had the tremendous pleasure of collaborating with University of Galway for more than 20 years now. This relationship has provided our firm with a proud line of inquisitive, mature and resilient graduates that have made a real difference in our business and for the clients we serve. “University of Galway’s commitment to industry collaboration, feedback and continuous improvement are attributes we value in our relationship. These reflective qualities are also evident in the graduates we have had the pleasure to welcome to EY. We are proud to formalise our partnership with University of Galway and look forward to many more years of collaboration and success.” During his visit to the campus, Mr White delivered guest lectures and met students interested in pursuing a work placement or graduate opportunities organised by the University’s Career Development Centre through their Employer in Residence programme. Mr White was the first University of Galway student to undertake a placement with EY Luxembourg 20 years ago. Professor Alma McCarthy, Executive Dean of the College of Business, Public Policy and Law, said of the partnership: “We are delighted to officially launch this partnership with EY.  It is a very valuable learning experience for students ensuring the curriculum is future-focused and they are industry-ready on graduation. The partnership builds on many years of successful collaboration between EY Luxembourg and University of Galway’s J.E. Cairnes School of Business and Economics.” Professor Karena Yan, Dean of J.E. Cairnes School of Business and Economics, added: “This partnership brings world-class professional insight to Galway and opens international opportunities for our students in Luxembourg and beyond. By combining mentoring, guest teaching and meaningful work placements, we’re preparing graduates to lead responsibly in the financial services sector and to deliver impact for business and society.” Ends

An international research team has created a roadmap for the integration of sex and gender in medical research. The PAINDIFF network, led by University of Galway Centre for Pain researchers, brings together 32 international experts from 22 institutions across eight countries to address one of the most persistent gaps in biomedical science with barriers and inconsistencies in how sex and gender are accounted for in study design, data analysis and reporting. The results of the project have been published in Nature Neuroscience https://www.nature.com/articles/s41593-025-02164-1 Senior author and consortium coordinator Dr Michelle Roche said: “For too long, medical research often assumed that biological mechanisms and treatment responses are the same for males and females. Historically, males were more commonly used in preclinical research and while clinical research included more balanced participation, data was not routinely analysed or separately by sex.” The research team noted that increasing evidence now shows meaningful differences between males and females in disease prevalence, biological pathways and responses to treatment. Dr Roche added: “As medical research moves toward personalised medicine, it is increasingly clear that understanding sex and gender differences and similarities is essential for improving health outcomes. The PAINDIFF network has developed guidelines and recommendations for studies in this field. Widespread adoption and implementation of these recommendations will reduce variability, improve reproducibility, and enhance the translatability of research findings, within and beyond the field of pain.” Professor David Finn, joint first author on the paper, said: “Chronic pain is a clear example of a condition where there are important sex and gender differences.  It affects one in five people worldwide, with women accounting for 70% of those affected.  Our new paper aims to reset the basic requirements for medical research, offering 13 actionable recommendations to guide researchers, reviewers, funders and policymakers, creating a clear and comprehensive roadmap for integrating sex and gender.” The recommendations include five universal principles applicable across all types of research — such as including both males and females as standard practice, and analysing and reporting data by sex. They also address how gender, distinct from biological sex, should be meaningfully incorporated into research frameworks.   Professor Brian McGuire, joint first author, said: “Historically, there have been deficits, barriers and inconsistencies surrounding the inclusion and study of sex and gender in research. Our paper provides a framework and roadmap for researchers and other stakeholders on how best to include and study sex and gender in research on pain and other biopsychosocial fields going forward.” The research was carried out under the ERA-NET NEURON initiative, funded by the European Union and the Health Research Board, and led by Dr Michelle Roche, Professor David Finn and Professor Brian McGuire at the University of Galway’s Centre for Pain Research. The 13 PAINDIFF recommendations published under three themes are:  Universal Recommendations Include males and females as standard practice unless there is a valid reason not to do so. Account for sex in randomization/counterbalancing/testing order Use adequately powered study design to detect sex differences when it is the primary experimental variable or when data suggest sex-specific effects  Include detailed reporting of experimental design including sex of the experimenter when possible Conduct sex-disaggregated analysis and reporting Preclinical Researchers should be aware of, and report on, the sex of the established cell lines, primary cells and tissues used in their research It is not always necessary to test for oestrous cycle stage Researchers should include detailed reporting on housing, environmental conditions and experimental design Clinical Ask for participants’ sex assigned at birth and self-identified gender Include a “prefer/choose not to say” response option when asking about sex and gender Include an open textbox response option to capture gender identity followed by a series of tick boxes to aid categorisation Report the number of people who hold diverse gender identities and, where possible and permitted, make the raw data accessible for further study (while ensuring anonymity).  When possible, collect and report on sex-specific variables to allow disaggregated analysis by sex or gender to be better informed by hormonal status, rather than solely by age. Ends

Scientists have discovered a new approach to growing mini-brains in the lab which gives them long enough lifespan to explore function and disease in cells.    The research team led by Dr Mihai Lomora, a scientist with CÚRAM - the Research Ireland Centre for Medical Devices based at University of Galway, grew the small blobs of brain cells in a soft, biologically compatible material called a hydrogel and introduced cells that can form blood vessels.    The result was that the cerebral organoids grew larger with fewer cells dying in the centre, and they mimicked features of the protective blood-brain barrier, potentially making them more relevant lab models to study diseases such as stroke, Alzheimer’s, and Parkinson’s Disease.   The findings have been published in the prestigious journal Advanced Science.   Dr Lomora, a lecturer in Biomaterial Chemistry, lead of the CerebroMachines Lab and member of the Institute for Health Discovery & Innovation, University of Galway, said: “Growing ‘mini-brains’ in the lab might sound like science fiction. But it’s not so far-fetched. Scientists around the world today grow small ‘cerebral organoids’ made of brain cells.   “When we started the project, we could see in the scientific literature that cerebral organoids growing in the lab tended to have a vasculature or blood vessels that were superficial only. That meant that the blood vessels didn’t penetrate in to reach the deeper cells in the organoid, then these cells became starved of oxygen and nutrients over time and they died off.”   The research project involved a multi-disciplinary team based in CÚRAM, University of Galway, RCSI University of Medicine and Health Sciences, Trinity College Dublin and the University of Edinburgh.   The team took an approach to help overcome the issue of viability of an organoid – tiny clumps of tissue, only a few millimetres across and just about visible to the naked eye. One of the main problems with these collections of brain cells is that as they get bigger, a lack of blood supply means the inner core dies off.   In order to get enough oxygen and nutrients to all of the cells, researchers adapted an existing protocol, or recipe, for growing the cerebral organoids, experimenting with different environments and timings to optimise the ability of blood vessels to reach these deeper cells.    The more blood-vessel-friendly approach resulted in three times less cell death in the organoids, and the researchers saw evidence that the organoids contained characteristics of an important protective feature naturally found in the brain called the blood-brain barrier.   Dr Lomora added: “We were fascinated to see that the vasculature really was able to protrude towards the interior of the organoids, which actually was quite a big advancement. And we also saw that cells involved in forming some of those blood vessels came from the organoid itself.  It's at the edge of the state of the art for now.  “Obviously this is not the same as growing a brain in the lab, but it is a mini-model of how parts of the brain work, and we want it to be as physiologically relevant as possible. We believe that by increasing the vasculature we have taken steps to making the organoids more physiologically relevant.”   The organoids are now being used by researchers in the CÚRAM network to explore brain function and disease, including stroke.   The research paper is available at Advanced Science.   Ends     

A University of Galway academic has been appointed Chief Scientist of the Food and Agriculture Organization (FAO) of the United Nations.  Charles Spillane is Established Professor of Plant Science in the School of Biological and Chemical Sciences and Ryan Institute and leads the AgriBiosciences, Food Security and Climate Change research lab in the University.  Professor Spillane joins the Core Leadership team of the Food and Agriculture Organization - the inter-governmental specialised agency within the United Nations system which leads international efforts to defeat hunger and achieve food security for all.  It is the first time an Irish person has been appointed to such a high leadership position in the FAO since its foundation in 1945.  The mission of the FAO is focused on three goals: the eradication of hunger, food insecurity and malnutrition; the elimination of poverty and the driving forward of economic and social progress for all; and the sustainable management and utilisation of natural resources, including land, water, air, climate and genetic resources for the benefit of present and future generations.  Minister for Agriculture, Food, Fisheries and the Marine, Martin Heydon T.D., said: “The appointment of Professor Charles Spillane as Chief Scientist of the Food and Agriculture Organization of the United Nations is a significant achievement for Ireland, the University of Galway and for Professor Spillane personally. He brings deep expertise in agricultural bioscience, climate-resilient food systems and sustainability, built through decades of leading interdisciplinary research at the University of Galway. His appointment will further strengthen the FAO’s capacity to advance evidence-based innovation and partnerships for resilient, inclusive and sustainable agrifood systems worldwide.”  Professor David Burn, President of University of Galway, said: “We are delighted that Professor Spillane has been appointed to this position of exceptional public service with the United Nations Food and Agriculture Organization. Professor Spillane’s appointment to this globally leading role is a testament to University of Galway’s rapidly growing reputation in agricultural research and education for food security and international development, that has been achieved over the past decade.”  Professor Charles Spillane, University of Galway, said: “I am deeply honoured to be appointed as Chief Scientist within the Food and Agriculture Organization of the United Nations. I am taking on this role with profound respect for the Organization’s remarkable history and enduring mandate to achieve food security for all, and to ensure that people everywhere have regular access to sufficient, nutritious food. The Food and Agriculture Organization is a key enabler of the world’s shared commitment to a simple but powerful idea, namely that that no person should go hungry, and that the pursuit of food security is inseparable from the pursuit of peace, prosperity, and dignity.”  The Food and Agriculture Organization is the United Nation’s lead agency for SDG2 (Sustainable Development Goal 2) - Zero Hunger and is the custodian agency responsible for 21 of the United Nation’s Sustainable Development Goal indicators.  It was founded in 1945 in response to the multiple global food crises that followed World War II. It is governed by its 195 members, namely 194 Member States and the European Union, operating on a consensus-based one country, one vote system. Ireland is one of the Member States, where the Department of Agriculture, Food and the Marine leads the state’s engagement.  The FAO has an annual budget of over US$2billion, with more than 16,000 staff working across the headquarters in Rome, five regional offices and 130 country offices.  Read more information about the Food and Agriculture Organization of the United Nations here: www.fao.org.Ends

University of Galway, in partnership with the HRB Diabetes Collaborative Clinical Trial Network, has announced the inaugural A.Menarini Pharmaceuticals Ireland Scholarship.  The successful student is Ruth Alejandra Huerta Sinesio, originally from Mexico City, who was awarded the scholarship for her outstanding achievements and commitment to advancing diabetes research and patient care.  The A.Menarini Pharmaceuticals Ireland Scholarship, supported by Galway University Foundation, provides full financial support for a student in the Master of Science in Clinical Research.  Ruth Alejandra Huerta Sinesio was selected from a highly competitive field of candidates, demonstrating a strong dedication to improving health outcomes through her work and experience. The award will enable her to pursue advanced training and to contribute to pioneering research activities, as well as strengthening her role within the Diabetes Collaborative Clinical Trial Network and broader diabetes community.  Professor Fidelma Dunne, Director of the HRB Diabetes Collaborative Clinical Trial Network and the Institute for Clinical Trials at University of Galway, said: “We are immensely proud of Ruth Alejandra and all she has accomplished to date in her career. Her passion, drive, and commitment embody exactly what this scholarship stands for. We are deeply grateful to A.Menarini for their generous support, which enables us to nurture the next generation of clinical researchers who will make a transformative difference in Ireland and far beyond. Their investment in education and research ultimately supports the lives of people living with diabetes.”  Ruth Alejandra Huerta Sinesio said: “This scholarship motivates me to keep striving for excellence. I’m grateful to A. Menarini for this award, which supports my professional growth and my mission to address a major public health challenge. It’s an honour to be supported by a community that believes in students’ ability to improve care for people with diabetes. I hope to turn my experience and motivation into lasting impact, honouring my loved ones and improving lives worldwide.”  As part of A.Menarini Pharmaceuticals Ireland support for students at University of Galway, the company will provide three further annual scholarships in the coming years to support students demonstrating academic excellence, leadership, community engagement, or financial need. The company has also pledged support for education and training within the HRB Diabetes Collaborative Clinical Trial Network, including professional development, multidisciplinary training and expanded Patient and Public Involvement (PPI) initiatives. The investment will strengthen Ireland’s capacity to deliver world-class clinical research and foster a new generation of leaders dedicated to improving diabetes care across the globe.  Ends

RePEAT research project showcases scale of digitisation of 19th century bog maps University of Galway has announced the launch of the All-Ireland Peatlands Centre of Excellence to lead research and policy development on restoration and conservation of bogland.  The Centre has been established at the University’s Ryan Institute to help address critical challenges linked to peatlands, including decarbonisation, biodiversity loss, just transition and cultural heritage.  Along with academic research and policy development, it will also serve as a hub for innovation and training in relation to protection of peatlands on the island of Ireland and overseas.  The establishment of the All-Ireland Peatlands Centre of Excellence builds on a strong collaborative ethos among multiple universities, government agencies and community groups.  It also follows on from the RePEAT project, a research collaboration involving University of Galway and Trinity College Dublin which identified former peatlands areas that are suitable for alternative management and informs national bog rewetting projects to reduce greenhouse gas emissions.  Using Bog Commissioner maps from the 19th century which were originally designed to facilitate drainage, RePEAT researchers digitised the maps and turned them against their initial purpose in order to establish the original baseline extent of peatlands. The maps recorded the large-scale survey of more than 1 million acres of bogs between 1810 and 1814.   The RePEAT project was funded by the Department of Agriculture Food and Marine and the Environmental Protection Agency.  Dr Terry Morley, Lead of the new All-Ireland Peatlands Centre of Excellence and researcher on RePEAT project, Ryan Institute, University of Galway, said: “The All-Ireland Peatlands Centre of Excellence will bring together scientists, policymakers, landowners, and communities.  “We hope that through this new Centre of Excellence we will be able to strengthen national capacity for sustainable peatland management and ensure long-term environmental and societal benefits from restoration and conservation.  “University of Galway is uniquely situated to lead this centre, with blanket and raised bogs at our doorstep and broad interdisciplinary peatland research expertise.”  Dr John Connolly, a researcher on the project from Trinity College Dublin, said: “The RePEAT project has identified more than 200,000 hectares of former peatland, which is now in other land uses. These areas represent emissions many times higher than their baseline and can be used to identify areas that may be suitable for restoration and rewetting under Ireland’s Climate Action Plan.”  A special showcase outlining the findings of the RePEAT research project is being hosted in the Orbsen Building on the University of Galway campus from Monday December 15th-19th while a public lecture will be held on Thursday, December 18th at 5pm in the Michael D Higgins Auditorium.  Ends

Three consortia involving University of Galway researchers have received funding for innovative medtech, life sciences and AI-driven projects that will transform healthcare and drive improved patient outcomes.  The funding, announced by Minister for Enterprise, Trade and Employment, Peter Burke T.D., is part of the latest tranche of awards from the Government’s Disruptive Technologies Innovation Fund (DTIF). University of Galway is part of 38 consortia which have successfully applied for investment through partnerships with regional and national SMEs and institutions. The three projects awarded funding in the latest round are: The PIONEER project – a pathology and immuno-oncology with next-generation screening and electroporation for enhanced response in cancer therapy. The project is in partnership with Mirai Medical, Deciphex, Eurofins, University of Galway, Trinity College Dublin and University College Dublin. It has been awarded €7.2 million. The HealAsystant project - an AI-assisted self-management support system for compression therapy. The project is in partnership with University of Galway spin-out FeelTect, Professional Granite Consulting and University of Galway. It has been awarded €6.3 million. The RECAP project – a therapy and personalised post-treatment support for people with chronic musculoskeletal pain. It will involve a series of clinical trials that will combine two complimentary technologies. The project is in partnership with CrannMed, Salaso Health Solutions, University of Galway’s Institute for Clinical Trials and RCSI University of Medicine and Health Sciences. It has been awarded €6.6million. Professor David Burn, President of University of Galway, said: “I am delighted to see University of Galway's continued success in awarded funding from the Government’s Disruptive Technologies Innovation Fund programme. Congratulations to all involved in this huge achievement and to the consortium of partners and those from the Galway region. “These projects are a testament to the world-class research innovations in medtech, life sciences and AI-driven healthcare being developed at University of Galway to solve global challenges facing our society. The collaborative nature of our partnerships with institutions and enterprises demonstrates our ongoing commitment to advancing impactful research solutions.” The Disruptive Technologies Innovation Fund finances collaboration between SMEs, multinationals and research institutions towards the development of the next wave of high-value innovation. The total investment of over €19 million was made under the Government’s Call 7 of the Disruptive Technologies Innovation Fund. Ends

New research into the arrangement of sugar chains or ‘glycans’ in the cells of the spine has shed light for the first time on the critical role it plays in the complex process of disc degeneration.   Researchers at CÚRAM - Research Ireland Centre for Medical Devices at University of Galway, together with a team of international colleagues, carried out a comprehensive investigation into the different characteristics of glycans in healthy and degenerated intervertebral discs.   It is the first time that the whole human disc glycome in the spine - the entire set of sugar chains that modify human proteins and lipids - have been analysed in this way.    Intervertebral disc (IVD) degeneration is a major cause of low back pain, a significant global health issue. While glycosylation is critical for cellular signalling and inflammation, its malfunction can lead to diseases and its role in IVD degeneration has remained poorly understood until the research was conducted.   Dr Kieran Joyce, first author of the paper, said: “From this research, we now know which sugars are expressed in the degenerated or diseased disc states, so we can design therapies to target this.   “We observed distinct alterations in glycan expression, notably an overabundance of sialic acid on the surface of the cells in degenerated discs and decreased branching, which are associated with IVD degeneration. These observed differences have implications for regulating inflammatory responses and other cellular activities.”   Professor Abhay Pandit, Scientific Director of CÚRAM and senior author of the research paper, said: “Our findings suggest that there is therapeutic potential in using biomaterial systems to intervene and alter the way proteins and glycans attach to each other to reduce inflammation associated with IVD degeneration. This research significantly advances our knowledge of the glycomic mechanisms underlying IVD degeneration and opens new avenues for developing therapies to restore disc physiology.”   The finding of the research have been published in Advanced Science and can be accessed at https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202506669?af=R.   The project was carried out by CÚRAM researchers at University of Galway in collaboration with colleagues at Maynooth University, University College Dublin, the National Institute for Bioprocessing Research and Training (NIBRT), the Medical University of South Carolina and the Institute of Chemical Technologies and Analytics in Austria.   Ends

University of Galway’s Institute for Clinical Trials has been awarded the 2025 Collaboration in Medtech Award at the Irish Medtech Awards.  The accolade recognises the Institute’s outstanding leadership in advancing early-stage medtech innovation through high-impact clinical partnerships, including the establishment of the Hypercare initiative to supports partners in the clinical trials approval process.   It is the second year in a row in which University of Galway has won the Collaboration in Medtech Award.   Established in 2023, the Institute for Clinical Trials is focused on transformation of the clinical research landscape in Ireland by creating an environment where scientific advances are translated into improved care for patients.  The 2025 Collaboration in Medtech Award was secured for the Institute’s Hypercare initiative, which has been developed to transform how early-stage medtech trials are delivered in Ireland. The initiative is a national pilot, designed to support  industry collaborators in navigating complex approval processes for a clinical trial, from ethics and regulatory submission to system requirements of the Health Service Executive, through to initial patient enrolment.   Aligned with the mission of the Institute for Clinical Trials, this project drives excellence, inclusivity, and need-driven research to improve global health outcomes. Clinical trials increase the opportunities of patients to have early access to innovative treatments that could improve, extend or even save their lives.  Encouraging more research must be a priority for those bodies charged with improving the nation’s health and the Hypercare initiative seeks to support this by ensuring Ireland is a location of choice for early feasibility/phase MedTech trial conduct and delivery. The Hypercare project aims to highlight positive changes in the delivery of clinical research in Ireland, attracting further interest and investment from MedTech stakeholders nationally and internationally.             Professor Fidelma Dunne, Director of the Institute for Clinical Trials at University of Galway, said: "It is a real honour for the Institute to win the 2025 Collaboration in Medtech Award. Collaboration is at the heart of everything we do at the Institute for Clinical Trials, and this recognition reflects the commitment of our team and our partners.   “The Hypercare initiative stands out as the model for academic–industry collaboration, advancing innovation while upholding the highest clinical and regulatory standards. By working closely with innovators, from early-stage start-ups to global leaders, we are making great strides in demonstrating where Ireland can lead in the world of clinical trials as well as accelerating the delivery of new technologies that can truly improve patient outcomes at home and across the globe."            Hypercare has successfully supported four companies to date through the pilot, two of which have launched a first-in-human use of their device in Ireland – Medtronic and Intervene.   By bringing together clinical expertise, regulatory guidance, and real-world testing, the Institute helps partners move through approvals in a more structured and predictable process and therefore more quickly through early clinical validation with the hope of bringing new helathcare solutions to patients in Ireland and beyond.  The Collaboration in Medtech Award celebrates the Institute’s success in forging partnerships that strengthen Ireland’s position in medtech and support a more collaborative, efficient, and innovative approach to clinical research.  Irish Medtech, the Ibec group that represents the medtech sector, Enterprise Ireland and IDA Ireland held the awards as part of Medtech Rising, an annual conference for the sector held this year at The Galmont Hotel in Galway.  Ends 

University of Galway has announced the recipients of its Writer in Residence and Digital Artist in Residence awards for 2026. Creative Writer in Residence, Nicole Flattery and Digital Artist in Residence, Jane Cassidy will take up their positions at University of Galway in early 2026. Westmeath author and short story writer, Nicole Flattery is best known for her award-winning short story collection, Show Them A Good Time and her debut novel Nothing Special, as well as being a literary critic and podcaster. Jane Cassidy is a multidisciplinary artist and educator from Galway. Trained in music and digital media, Jane's main interests lie in audio-visual immersive environments, visual music and synaesthesia. Both artists’ work reflects the diversity and richness of Ireland’s creative landscape through literature and digital arts.   The awards, which are jointly funded by the Arts Council and the University, provide artists with dedicated workspaces and vital finances to develop their work, acquire resources and further Ireland’s vibrant creative scene. Dr John Kenny, Director of the BA in English and Creative Writing, School of English, Media and Creative Arts, University of Galway, said: “Our ongoing partnership with the Arts Council for this Residency has been of tremendous benefit to our Creative Writing programmes in the School. It brings additional cutting-edge literary talent into our classrooms, and it inspires our students and wider learning communities on campus and in the Galway region, by highlighting the new presence of a writer who will be engaging in their own artistic practice while spending the year developing creative ideas and conversations with us. “Nicole Flattery has featured previously as a practitioner-teacher in the Department of English, and we are thrilled to be welcoming her back for the coming year. Nicole is one of the major internationally recognised artists of literary prose among the younger generations of Irish writers, and she is also a highly esteemed literary critic and podcaster. We look forward to working with her as she finishes her next book and fosters her own inventive approach to this Residency.” This year marks a particularly exciting opportunity for Digital Artists, who have, for the first time, been included in the programme through pilot residencies. Dr Conn Holohan, Director of the Centre for Creative Technologies, University of Galway, said: “We are delighted to welcome Jane Cassidy to the Centre for Creative Technologies as the University of Galway Digital Artist in Residence. Jane’s commitment to co-creation and inclusive digital arts practice resonates strongly with the ethos and activities of the Centre. We are particularly excited about the opportunities this residency creates for students, academic researchers, and the wider creative community to engage directly with Jane’s work through workshops, co-creative projects, and public events, expanding access to the digital arts across the campus and beyond.” The Artists in Residencies programme is a cornerstone of the Arts Council’s commitment to fostering artistic excellence and enriching educational environments. Maura McGrath, Chair of the Arts Council, said: “As Chair of the Arts Council, I am delighted to congratulate the new Artists in Residence across our universities. These programmes support artists to deepen their practice while bringing fresh creative energy into teaching, research and campus life. By connecting students and staff with professional artists, they spark new ideas and show how creativity can enrich every discipline. We are very grateful to our university partners for their ongoing commitment to these residencies.” Ends

Consortium of CrannMed Ltd., Salaso Health Solutions Ltd., University of Galway and RCSI University of Medicine and Health Sciences secure €6.6m funding through Disruptive Technologies Innovation Fund   A consortium of medtech and digital healthcare companies and university researchers are to launch a series of world-first clinical trials focused on bringing long term relief to people suffering from chronic musculoskeletal pain.   The partnership of CrannMed, Salaso Health Solutions, University of Galway’s Institute for Clinical Trials and RCSI University of Medicine and Health Sciences has been awarded €6.6million Government investment. The funding, announced by Minister for Enterprise, Trade and Employment, Peter Burke T.D., is part of the latest tranche of awards from the Disruptive Technologies Innovation Fund. The consortium will carry out the RECAP project - Resorbable Embolization for Chronic musculoskeletal Pain. The series of clinical trials taking place as part of the project are being coordinated by University of Galway’s Institute for Clinical Trials and RCSI University of Medicine and Health Sciences. The trial programme combines two complimentary technologies to improve outcomes for people with chronic musculoskeletal pain. Patients will have access to breakthrough pain treatment developed by CrannMed and a recovery programme developed by Salaso with the support of clinical specialists. In the first trial, a patient will receive an injection which will selectively block blood flow to the site of pain, reducing inflammation and stray nerve endings, which are ultimately the root cause of the pain. Patients who have experienced chronic pain need to pursue a structured recovery process aimed at building strength and improving the resilience of musculoskeletal tissues. The second trial assesses the patient’s recovery as they are supported by an AI enabled self-management platform in real-time. Furthermore, the trials will allow scientists and researchers within the clinical centres to develop new imaging techniques, smart trial designs and pain measurement methodologies that will be needed to make the solution standard within healthcare systems.  Liam Farrissey, CrannMed Chief Executive Officer, said: “It is very rewarding to be able to put to put such a high quality consortium together from within the Irish eco-system. The consortium covers development, manufacture, clinical validation and AI enabled patient engagement all from within world class teams operating in the country. An exciting benefit is that we will be able to offer our treatment to Irish patients much earlier than would otherwise be possible. If we are successful, it can pave the way to change the way we treat chronic pain.”                Aoife Ní Mhuirí, Salaso, said: “Using AI to increase engagement with clinically prescribed self-management programmes will lead to improved patient outcomes while minimizing the time required from physicians or therapists to oversee post-procedure care. Treatment and recovery can happen closer to home, saving time and money for patients and the health system. The approach is more sustainable, more accessible for patients, and has the potential to set a new global standard for pain management.”   Professor Fidelma Dunne, Director of the Institute for Clinical Trials at University of Galway, said: "This project is set to revolutionize how chronic joint and muscle pain is treated. The innovative treatment and clinical trial will enable patients to get effective, long-term pain relief from chronic pain without surgery or addictive drugs. This project is an example of academic-industry collaboration at its best and the Institute for Clinical Trails is delighted to support these type of partnerships by providing clinical trial expertise to our industry innovators and ensuring accelerated access to innovative treatments for patients.”   Professor Fergal O’Brien, Deputy Vice Chancellor for Research and Innovation at RCSI, said: "RCSI is proud to support innovative Irish medtech through first-in-human clinical trials conducted here in Ireland. This collaboration shows that Ireland is open for business in clinical research, and RCSI is committed to working with Irish companies to deliver transformative health solutions for patients.”   University of Galway’s Institute for Clinical Trials has a pivotal role in the project, focused on clinical trial leadership, innovation in trial design and overall coordination and delivery of the clinical trial programme for the Disruptive Technologies Innovation Fund.   RCSI’s role in the project is to lead the development and validation of imaging and access protocols for direct injection of the CrannMed technology and conduct the first-in-human clinical use of the technology. Additionally, RCSI will contribute expertise in digital health to optimise patient engagement with the AI-enabled rehabilitation platform.   The consortium stated that the combined benefits of the treatment and technologies being trialled are expected to be tens of times better than steroid injections, which are the current standard of care for chronic musculoskeletal pain conditions.   The €6.5m investment was made under Call 7 of the Disruptive Technologies Innovation Fund.   Ends

Fuair Cuibhreannas CrannMed Ltd., Salaso Health Solutions Ltd., Ollscoil na Gaillimhe agus Coláiste Ríoga na Máinleá in Éirinn maoiniú €6.5m tríd an gCiste Nuálaíochta Teicneolaíochtaí Suaiteacha   Tá cuibhreannas de chomhlachtaí teicneolaíochta leighis, cúraim sláinte digití agus taighdeoirí ollscoile ag seoladh sraith trialacha cliniciúla den chéad uair ar domhan, dírithe ar fhaoiseamh fadtéarmach a thabhairt do dhaoine atá ag fulaingt le pian ainsealach mhatánchnámharlaigh. Bronnadh infheistíocht rialtais €6.5 milliún ar an gcomhpháirtíocht idir CrannMed, Salaso Health Solutions, an Institiúid do Thrialacha Cliniciúla in Ollscoil na Gaillimhe agus Coláiste Ríoga na Máinleá in Éirinn. Tá an maoiniú, arna fhógairt ag an Aire Fiontar, Trádála agus Fostaíochta, Peter Burke T.D., mar chuid den tráinse is déanaí de dhámhachtainí ó Chiste Nuálaíochta Teicneolaíochtaí Suaiteacha. Tá an tsraith trialacha cliniciúla á comhordú ag an Institiúid do Thrialacha Cliniciúla in Ollscoil na Gaillimhe agus ag Coláiste Ríoga na Máinleá in Éirinn. Comhcheanglaíonn clár na dtrialacha dhá theicneolaíocht chomhlántacha chun torthaí a fheabhsú do dhaoine atá ag fulaingt le pian ainsealach mhatánchnámharlaigh. Beidh deis ag othair teacht ar chóireáil cheannródaíoch do phian atá forbartha ag CrannMed agus ar chlár téarnaimh atá forbartha ag Salaso le tacaíocht ó speisialtóirí cliniciúla. Sa chéad triail, gheobhaidh othar instealladh a choisceann sreabhadh fola chuig suíomh na péine, rud a laghdóidh athlasadh agus néarchinn fhánacha, atá mar phríomhchúis leis an bpian. Tar éis na cóireála tosaigh, déanfaidh an dara triail measúnú ar théarnamh an othair agus tacaíocht á fáil acu ó sheirbhís dhigiteach féinbhainistíochta bunaithe ar an Intleacht Shaorga. Bíonn ar othair, a bhfuil pian ainsealach orthu, tabhairt faoi phróiseas téarnaimh struchtúrtha le neart a fhorbairt agus le hathléimneacht fíochán matánchnámharlaigh a fheabhsú. Ina theannta sin, cuirfidh na trialacha ar chumas eolaithe agus taighdeoirí sna hionaid chliniciúla teicnící nua íomháithe, dearaí trialacha cliste agus modheolaíochtaí tomhais péine a fhorbairt a bheidh de dhíth chun an réiteach seo a dhéanamh caighdeánach laistigh de chórais cúraim sláinte.             Dúirt Liam Farrissey, Príomhfheidhmeannach CrannMed: “Is mór an sásamh dúinn a bheith in ann cuibhreannas ar chaighdeán chomh hard a chur le chéile anseo in Éirinn. Cuimsítear leis an gcuibhreannas réimse leathan scileanna – taighde agus forbairt na gcoincheap, déantúsaíocht, bailíochtú cliniciúil agus tacaíocht na hintleachta saorga d’fhéinbhainistíocht othar; agus tá an saineolas ar fad ag teacht ó fhoirne den scoth atá ag feidhmiú sa tír. Buntáiste iontach amháin a bhaineann leis seo is ea go mbeimid in ann ár gcóireáil a chur ar fáil d’othair Éireannacha i bhfad níos luaithe ná mar ab fhéidir murach sin. Má éiríonn linn, d’fhéadfadh sé bealach nua a leagan amach chun cóireáil a chur ar othair a bhfuil pian ainsealach orthu.”             Dúirt Aoife Ní Mhuirí, Salaso: “Tríd an intleacht shaorga a úsáid chun rannpháirtíocht a mhéadú le cláir féinbhainistíochta atá leagtha amach go cliniciúil, beidh torthaí níos fearr ag othair agus laghdófar an méid ama a bheidh ar dhochtúirí nó ar theiripeoirí maoirseacht a dhéanamh ar chúram iarghnáthaimh. Is féidir an cóireáil agus an téarnamh a dhéanamh níos gaire do bhaile, rud a shábhálann am agus airgead ar othair agus ar an gcóras sláinte. Tá an cur chuige níos inbhuanaithe, níos inrochtana d’othair, agus tá an cumas aige caighdeán domhanda nua a leagan amach maidir le bainistíocht péine.”             Dúirt an tOllamh Fidelma Dunne, Stiúrthóir na hInstitiúide do Thrialacha Cliniciúla in Ollscoil na Gaillimhe: “Tá sé i gceist ag an tionscadal seo réabhlóid a dhéanamh ar an gcaoi a gcuirtear cóireáil ar phian ainsealach sna hailt agus sna matáin. Cuirfidh an chóireáil nuálach agus an triail chliniciúil ar chumas othar faoiseamh éifeachtach, fadtéarmach a fháil ó phian ainsealach agus ní bheidh gá le máinliacht ná le drugaí andúile. Is sampla den chomhoibriú is fearr idir an earnáil acadúil agus tionsclaíochta é an tionscadal seo agus tá ríméad ar an Institiúid do Thrialacha Cliniciúla tacú leis na comhpháirtíochtaí seo trí shaineolas trialach cliniciúil a chur ar fáil.”             Dúirt an tOllamh Fergal O’Brien, Leas-Seansailéir Taighde agus Nuálaíochta in RCSI: “Tá bród ar RCSI tacú le teicneolaíocht leighis nuálach Éireannach leis na chéad trialacha cliniciúla ar dhaoine anseo in Éirinn. Léiríonn an chomhpháirtíocht seo go bhfáiltítear anseo in Éirinn roimh chomhoibriú i réimse an taighde chliniciúil, agus tá RCSI tiomanta do bheith ag obair le comhlachtaí Éireannacha chun réitigh shláinte nua a sholáthar d’othair.” Dúirt an cuibhreannas go bhfuiltear ag súil go mbeidh na buntáistí a eascraíonn as an gcóireáil agus as na teicneolaíochtaí atá á dtriail deich n-uaire ar a laghad níos fearr ná instealltaí stéaróideacha, atá mar chaighdeán reatha cúraim i gcásanna péine ainsealaí matánchnámharlaigh. Rinneadh an infheistíocht €6.5m faoi Ghairm 7 den Chiste Nuálaíochtaí Teicneolaíochtaí Suaiteacha (DTIF). Críoch

More than 80 children with additional needs have enjoyed a unique opportunity to experience the magic of Christmas with a special visit to a Sensory Friendly Santa’s Grotto. The two-day event on December 5th and 6th was facilitated by staff and students from the School of Psychology at University of Galway, who took on the important roles of elves and Santa’s helpers. The annual Sensory Friendly Santa's Grotto has been a highlight of the year at University of Galway since 2017 and has grown to a weekend event, giving 48 families with additional needs the opportunity to visit Santa in a winter wonderland. Children received individualised, sensory-friendly gifts from Santa and had their photos taken, creating special Christmas memories. Dr Rachel Fitzpatrick, Dr Shauna Diffley, Dr Aoife McTiernan and Dr Helena Lydon from the School of Psychology coordinated the event, with a team of volunteer staff and students from the MSc in Applied Behaviour Analysis and final year students from the BSc Psychology programme at University of Galway. Dr Aoife McTiernan, Director of the MSc and PhD in Applied Behaviour Analysis and Lecturer in Psychology, University of Galway, said: “Visiting Santa is a cherished Christmas tradition, but busy grottos filled with noise, bright lights, and queues can be challenging for children with additional needs. The Sensory Friendly Santa’s Grotto at the University of Galway offers a calm, magical experience designed especially for these children and their families, often giving them their first opportunity to meet Santa.” Dr Rachel Fitzpatrick, Lecturer in Applied Behaviour Analysis, School of Psychology, University of Galway, said: “The event is made fully accessible and inclusive through small adjustments to the grotto and environment. Santa and the team connect with families in advance to help each child enjoy their visit at their own pace. It’s a true team effort, with Santa, the elves, and volunteers (staff and students from the School of Psychology) working hard behind the scenes to create real Christmas magic. We are deeply grateful to our generous sponsors across Galway and Ireland, and to the School of Psychology.” The organisers also hope to spread Christmas cheer by creating a freely available "How to Guide” on running similar inclusive and accessible Santa's Grotto events. The aim is that it will encourage other businesses and organisations across Ireland to provide this unique opportunity for more families of children with additional needs to experience the magic of meeting Santa. The event coordinators continued their annual tradition to collect for COPE's Christmas appeal with visitors and volunteers donating items for Christmas hampers for those in need.  Businesses from Galway and around Ireland sponsored the 2025 event and their generosity plays a critical role in making the magic of the event happen. Sponsors include Diligent, Liberty IT, Galway Camera Shop, Charlie Byrne’s Bookshop, 56 Central, Cregal Art, The Galmont, Connacht Hospitality Group, Irish Socksciety, Ground and Co, Smyths Toys Superstores, Supermac’s, The Galway Bay Hotel, Lidl and Home Store. Business sponsor, Ruairí Conroy, Site Lead, Diligent Galway, said: “At Diligent, we’re committed to supporting initiatives that create meaningful impact in our community. The Sensory Friendly Santa experience is a truly special event, it ensures every child has the chance to enjoy the magic of Christmas in a way that feels comfortable and accessible. We’re proud to support the incredible work that goes into making this experience possible for families across Galway.”   Ends

University of Galway has been awarded an institutional Silver Athena Swan award - a milestone in the University’s commitment to advancing equality and fostering an inclusive culture.   The Silver award recognises a strong institutional commitment to equality and clear evidence of progress and impact, building on the foundations of two previous Bronze awards.   The formal accreditation was given to the University at the National Athena Swan awards event in SETU, Carlow. University initiatives and interventions commended by Athena Swan Ireland in the award of the Silver accreditation include increasing the representation of women in senior academic grades and in leadership positions.  This includes:   A 15% rise in the proportion of females across all senior grades from 2015 to 2024.  The proportion of female senior lecturers in University of Galway has increased from 31% in 2017 to 47% in 2025.    The proportion of female professors has increased from 13% in 2017 to 30% in 2025.  In two other areas there has been further significant change with the proportion of female Heads of Schools increasing from 35% in 2017, to 56% in 2025, and the proportion of female Deans up from 14% in 2017, to 50% in 2025.  Alongside the institutional recognition, 14 of the University’s schools now hold Athena Swan awards – with 2 schools recognised with a Silver award, and 12 schools with Bronze. In 2024-2025, the J.E. Cairnes School of Business and Economics was awarded Silver; the School of Languages, Literatures and Cultures and the School of Political Science and Sociology received their first Bronze awards; and the School of Nursing and Midwifery and School of Psychology renewed their Bronze awards.  Professor David Burn, President of University of Galway, said: "I warmly congratulate our Vice-President for Equality, Diversity and Inclusion Dr Helen Maher, her team and the whole University community for their dedication in achieving an Athena Swan Silver institutional award. These awards are a testament to the sustained work of the University in improving gender equality and enhancing the lived experience of students and staff.   “Athena Swan at University of Galway now addresses not only gender, but the broader culture and experience of staff from all staff categories, embedding equality, diversity and inclusion into the fabric of University life. I look forward to working together with staff and students to continue our collaborative efforts and commitment to further advance equality and foster an inclusive culture at the University." Dr Helen Maher, Vice-President for Equality, Diversity and Inclusion at University of Galway, said: “Our new Silver Athena Swan accreditation is both an acknowledgement of how far we have come, and a reminder of our responsibility to continue to advance equality for all. This award reflects the vision and dedication of staff and students throughout our University community, and our shared commitment to making University of Galway a place where everyone feels valued and accepted. While we remain cognisant of the extensive work to do, we are proud of this progress and determined to build on it.” Athena Swan also praised the University’s 2025-2030 Equality Diversity Inclusion (EDI) action plan which is likely to drive substantial change in areas where issues have been identified. Robust internal Equality Diversity Inclusion (EDI) and governance structures within the University  were also noted, as was the annual funding of €3,000 for Athena Swan activities such as scholarships and events, at School and Unit level offered by the Office of the Vice President for Equality, Diversity and Inclusion. Over the past decade, led by the Office of the Vice President for Equality, Diversity and Inclusion, University of Galway has taken a proactive and collaborative approach to tackling historic challenges in relation to gender equality, leading to a genuine and sustainable cultural shift over time. Athena Swan is an internationally recognised charter for gender equality in higher education and research. In Ireland, it is overseen by Advance HE and supported by the Higher Education Authority. The Silver award places University of Galway among a select group of institutions demonstrating sustained, evidence-based change.   Sarah Fink, Head of Athena Swan Ireland, said: “This Silver Athena Swan award highlights the fantastic commitment of University of Galway in bringing about change through impactful and sustainable gender equality initiatives in higher education across Ireland. Congratulations to all those who work so hard to achieve and sustain this recognition.”  Jennie Rothwell, Centre of Excellence for Equality, Diversity and Inclusion, Higher Education Authority, said: "Action plans developed through the Athena Swan Ireland Charter enable higher education institutions and departments to take an evidence-based approach to addressing gender equality challenges. Congratulations to University of Galway in taking this step forward to advance gender equality for all staff and students." Ends

University of Galway is to take a major international role in supporting the media ecosystem and democratic development in Ukraine with a new cooperation agreement with President Volodymyr Zelensky’s government. The Memorandum of Cooperation was signed at a meeting in Dublin today, which was hosted by the First Lady of Ukraine Olena Volodymyrivna Zelenska. The agreement between University of Galway and the Government of Ukraine sets out joint work on democracy, media and public communication as the country continues to defend itself from the Russian invasion and sustained Russian disinformation efforts aimed at weakening European democracy and public trust. The agreement confirms the University as a partner in the Global Coalition of Ukrainian Studies, an international initiative coordinated by the Office of the President of Ukraine to strengthen academic cooperation and counter the effects of the ongoing war and the wider information threats facing Europe. President of University of Galway Professor David Burn and Associate Professor Tom Felle attended on behalf of the University. The agreement establishes a structured programme of cooperation on media literacy, democratic resilience and the rule of law. It reflects the University’s growing role in European debates on democracy and public communication and supports Ukraine as it continues to defend its sovereignty and progress towards European Union membership.  President of University of Galway Professor David Burn said: “Ukraine’s defence of democracy and European identity goes to the heart of our mission as a university for the public good. Galway has become a leading academic centre for work on media, democracy, digital governance and human rights, and our researchers influence policy discussions across Europe. This Memorandum strengthens that work in partnership with Ukraine at a moment of sustained pressure on democratic institutions and the information environment. It sets out the kind of contribution a university of our scale and ambition should make in Europe today.”  Associate Professor of Journalism and Media Tom Felle said: “Democracy relies on informed citizens and a resilient media system. Ukraine’s journalists, educators and students continue to work under extreme conditions. This agreement allows us to support them and to deepen academic cooperation while ensuring our own students engage directly with the realities of a country defending its freedoms. Galway is committed to playing a constructive role in this partnership and to working with institutions that share a commitment to democratic principles.”  University of Galway currently hosts more than 50 Ukrainian students across a wide range of disciplines. They include Vladyslav Piatin Ponomarenko whose documentary Imagine War, 75 Days of Survival in Mariupol won the Film Documentary of the Year award at the 2025 National Student Media Awards.  University of Galway is recognised internationally for its work on democracy, media and digital governance. Research at the University addresses disinformation, platform regulation, information integrity and the role of independent journalism in democratic life. It also contributes to European policy discussions on the Digital Services Act and the European Media Freedom Act and is known internationally for rigorous teaching and research in journalism and global media.  The partnership includes future cooperation with leading institutions in Kyiv, including the Mohyla School of Journalism at the National University of Kyiv Mohyla Academy and the Faculty of Journalism at Taras Shevchenko National University of Kyiv. Future planned activity includes joint teaching, guest lectures, shared research and opportunities for Ukrainian scholars and students to work with colleagues in Galway. The agreement will also embed Ukrainian case studies and expertise across media and democracy teaching at the University.  Ends   

 Professor John Canavan appointed to globally recognised research role  Professor John Canavan has been announced as the new UNESCO Chair in Children, Youth, and Civic Engagement at University of Galway.  The appointment has been marked with an inaugural lecture by Professor Canavan, exploring how society can advance knowledge and practice to improve the lives of children and young people.   The event showcased the work of the team of researchers working with the UNESCO Chair, as well as the values and guiding principles which underpin their work, and to demonstrate their contribution to the mission of UNESCO and the wider United Nations system.   Professor Canavan is a Personal Professor in Political Science and Sociology and the Director of the UNESCO Child and Family Research Centre, which he co-founded at University of Galway in 2007. The UNESCO Chair programme in Children, Youth and Civic Engagement at the University was established in 2008 and is delivered through the UNESCO Child and Family Research Centre.  Professor Canavan said: “My vision for the UNESCO Chair is to make a significant contribution to global policy and practice in the field of children and young people’s wellbeing, through our team’s scientific research and evaluation programme focused on Empathy, Mentoring, Youth as Researchers, Family Support and Alternative Education.”  The 2025-2029 programme for the UNESCO Chair in Children, Youth and Civic Engagement focuses on five thematic areas - youth empathy and civic engagement; youth mentoring; family support; youth engagement and participation; and alternative education. It also includes a number of objectives: to enhance and further develop existing work focusing on: Empathy/Social and Emotional Learning; Youth Mentoring; Alternative Education; and the Youth as Researchers (YAR) model. to develop a UNESCO position on family support as a policy paradigm that supports parents and wider family in meeting the needs of excluded children and young people in educational and inter-sectoral settings; and to embed policy and systems change as a cross-cutting theme across all work programmes seeking more effective bridging of policy and research worlds for greater societal impact. The former UNESCO Chair, Professor Pat Dolan, who held the role from 2008 to 2024, has been appointed Professor Emeritus at University of Galway. Ends  

Legal experts from around the world are to take part in a conference at University of Galway which aims to explore the options for conducting trials for terrorism and organised crime in Ireland. The two-day event - entitled Replacing the Offences Against the State Acts: The challenge of jury trials for terrorism and organised crime - will hear from legal academics and leading barristers from Ireland, the US, Australia and the UK. It is being hosted by University of Galway’s School of Law in association with Birmingham Law School on February 16th and 17th. Professor Donncha O’Connell, who was member of the Independent Review Group on the Offences Against the State Acts chaired by retired Court of Appeal Judge Michael Peart, which reported in June 2023, said: “Following on from the work of the Review Group – which published a majority and minority report but was unanimous in recommending repeal and replacement of the Offences Against the State Acts – this conference aims to explore the options open to Ireland when conducting trials for terrorism and organised crime, bearing in mind the priority attached to the right to trial by jury under the Irish Constitution.  “We hope to draw on the comparative expertise of academics and practitioners and relevant international standards in considering the likely shape of legislation to replace the Offences Against the State Acts at some stage in the future.” The conference will have a keynote address from Professor Fionnuala Ní Aoláin MRIA KC, Regents Professor and Robina Chair in Law, Public Policy & Society at the University of Minnesota and Professor of Law at Queen’s University Belfast.  Professor Ní Aoláin, who has just completed her mandate as UN Special Rapporteur on Human Rights and Counter-Terrorism, is a member of the International Commission of Jurists and was made an honorary King’s Counsel in recognition of her outstanding work. The conference will also hear from leading criminal barristers in Ireland and Scotland - Brendan Grehan SC, Alice Harrison BL and Ronnie Renucci KC - in a session focused on practitioner perspectives chaired by Supreme Court judge, Ms Justice Iseult O’Malley.  Mr Grehan - a graduate of University of Galway - has defended and prosecuted in the Special Criminal Court, most recently acting as defence counsel for Gerard Hutch who was acquitted of murder following the notorious Regency Hotel gun attack in 2016.  Ends

Professor Fidelma Dunne appointed Interim Director and John Kilmartin as Adjunct Professor   World-leading research academic Professor Fidelma Dunne has been appointed Interim Director of the Institute for Clinical Trials at University of Galway. Professor Dunne has an extensive background in clinical trial management and is ranked number 1 in Ireland and number 6 in the world for her research into gestational diabetes. The University has also announced John Kilmartin, former Vice-President of Regulatory Affairs at Medtronic and an independent medtech regulatory expert, joins the Institute for Clinical Trials as Adjunct Professor.  Mr Kilmartin has more than 30 years’ experience in the medtech industry, with a particular focus on the emerging regulatory and clinical frameworks in Europe. Professor Martin O’Donnell, Dean of the College of Medicine, Nursing and Health Sciences and Consultant Geriatrician at Saolta University Health Care Group, said: “We are honoured to have both Professor Fidelma Dunne and Mr John Kilmartin join the Institute for Clinical Trials. Their combined expertise in clinical trials, medical research and regulatory affairs will significantly contribute to our mission of advancing impactful clinical research. They will help to advance our clinical research goals and will make meaningful contributions to healthcare outcomes.” Professor Dunne said: “Clinical trials in new medicines and devices are vital to improving the health of people living in Ireland and worldwide. Improving health also has economic and societal benefits. Engaging in clinical trials allows patients in Ireland to receive new medicines and devices early. We have a track record of designing and delivering impactful clinical trials at University of Galway and I am delighted to lead the Institute for Clinical Trials which will have a pivotal role in further enhancing the clinical research landscape in Ireland.” Mr Kilmartin said: “The medtech industry is of huge importance to Ireland and Europe for the benefit of our patients, health systems and society. I believe that the Institute for Clinical Trials at University of Galway can play a key role in helping to support innovation in medtech by strategically targeting barriers within the Irish ecosystem. It aims to strengthen and further promote growth in the medtech sector, expand treatment options for patients and ultimately contribute to the advancement of healthcare on a broader scale." Bios Professor Fidelma Dunne is the immediate past President of the International Association Diabetes in Pregnancy Study Groups and President of the Irish Endocrine Society (2021-2024). Professor Dunne has demonstrated an unwavering commitment to advancing research and improving outcomes in the critical area of diabetes and pregnancy.  Her research interests, focused on diabetes and pregnancy, have resulted in an impressive portfolio of over 240 peer-reviewed publications, 12,000 citations, and significant grant funding.  Professor Dunne was honoured with the Jorgen Pedersen award in 2021 for her exceptional work in Diabetes in Pregnancy. She is the Principal Investigator of the EMERGE randomised controlled trial, funded by the Health Research Board, with ground-breaking results published in the Journal of American Medical Association (JAMA) in October 2023 which showed that the drug metformin provided a safe and effective way to treat gestational diabetes. John Kilmartin has a wealth of experience and knowledge in the medtech industry, having led global regulatory teams in the development and implementation of clinical and regulatory strategies for various medical devices and drug/device combination products. He is actively involved with various medtech industry associations, including MedTech Europe and the Irish MedTech Association (IMA), where he served as the Chair of the IMA Regulatory Steering Committee for a number of years.  Mr Kilmartin has a strong focus on the evolving regulatory and clinical frameworks around the world, having collaborated with regulatory agencies such as FDA, European Notified Bodies, Competent authorities and other international regulators. Mr Kilmartin’s areas of interest and focus include the development of the next generation of Regulatory and Clinical Affairs professionals, creating co-operative links between third-level institutions, the medtech industry, regulatory authorities, and government agencies to ensure that the medtech ecosystem continues to thrive in Ireland and in Europe.  Ends